Synthetic Biology Market to register high demand rate by 2024Talk Daily NewsSynthetic biology deals with the design and construction of new biological entities. It is an interdependent combination of biology and engineering for the construction of arti… Continue reading
Synthetic Biology Market to register high demand rate by 2024Talk Daily NewsSynthetic biology deals with the design and construction of new biological entities. It is an interdependent combination of biology and engineering for the construction of arti… Continue reading
Gene therapy product shows early promise in sickle cell diseaseHealioA 13-year-old boy with sickle cell disease showed no signs of the disease and resumed normal activities 15 months after an infusion of LentiGlobin BB305, according to a study conducte… Continue reading
NPR |
Embryo Experiments Reveal Earliest Human Development, But Stir Ethical Debate
NPR And in other experiments, he’s using human stem cells to create entities that resemble certain aspects of primitive embryos. Though Brivanlou doesn’t think these “embryoids” would be capable of developing into fully formed embryos, their creation has … |
OncLive |
Researchers looking at ways to target lingering cancer stem cells that cause disease relapse
News-Medical.net Chemotherapy treatment targets and kills cancer cells in the body. However, even after treatment, some cancer cells may remain in the patient’s system undetected. The lingering cancer can sometimes be in the form of cancer stem cells, which have two … Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain CancerOncLive |
Lincoln Journal Star |
Gene Therapy: A Breakthrough for Sickle Cell Anemia?
Lincoln Journal Star WEDNESDAY, March 1, 2017 (HealthDay News) — Researchers are reporting early success using gene therapy to treat, or even potentially cure, sickle cell anemia. The findings come from just one patient, a teenage boy in France. But more than 15 months … Gene Therapy Treats Sickle Cell Disease in Teenager Using Lentiviral VectorMedscape One boy’s cure raises hopes and questions about gene therapy for sickle cell diseaseSTAT Breakthrough: Gene Therapy Effective for Young Sickle Cell Patient …MedPage Today |
|
CRISPR patent ruling has little impact in laboratory setting, MIT researchers say
The Tech Researchers at MIT maintained that the U.S. Patent Trial and Appeal Board’s Feb. 15 decision, which affirmed the Broad Institute’s patent claims on using CRISPR-Cas9 technology to edit eukaryotic genomes, had little impact on future laboratory research. |